PepGen
      Website: www.pepgen.com
           12.9.20 Article: PepGen raises $45 million in Series A
            2.26.21 Article: PepGen forms Scientific Advisory Board
            8.5.21 Article: PepGen raises $113 million
            4.22 S1 filed with SEC stating filing IND for myotonic dystrophy drug candidate in first half of 2023
            12.7.22 Press Release discussing IND-enabling data and plans to commence Phase 1 trial in first half of 2023